732 related articles for article (PubMed ID: 27006281)
1. Higher detection rates of amino acid substitutions in HBV reverse transcriptase/surface protein overlapping sequence is correlated with lower serum HBV DNA and HBsAg levels in HBeAg-positive chronic hepatitis B patients with subgenotype B2.
Su M; Xiang K; Li Y; Li Y; Deng J; Xu X; Yan L; Zhuang H; Li T
Infect Genet Evol; 2016 Jun; 40():275-281. PubMed ID: 27006281
[TBL] [Abstract][Full Text] [Related]
2. Naturally occurring deletion/insertion mutations within HBV whole genome sequences in HBeAg-positive chronic hepatitis B patients are correlated with baseline serum HBsAg and HBeAg levels and might predict a shorter interval to HBeAg loss and seroconversion during antiviral treatment.
Hao R; Xiang K; Peng Y; Hou J; Sun J; Li Y; Su M; Yan L; Zhuang H; Li T
Infect Genet Evol; 2015 Jul; 33():261-8. PubMed ID: 25976382
[TBL] [Abstract][Full Text] [Related]
3. New amino acid changes in drug resistance sites and HBsAg in hepatitis B virus genotype H.
Fernández-Galindo DA; Sánchez-Ávila F; Bobadilla-Morales L; Gómez-Quiróz P; Bueno-Topete M; Armendáriz-Borunda J; Sánchez-Orozco LV
J Med Virol; 2015 Jun; 87(6):985-92. PubMed ID: 25732900
[TBL] [Abstract][Full Text] [Related]
4. Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA.
Xiang KH; Michailidis E; Ding H; Peng YQ; Su MZ; Li Y; Liu XE; Dao Thi VL; Wu XF; Schneider WM; Rice CM; Zhuang H; Li T
J Hepatol; 2017 Feb; 66(2):288-296. PubMed ID: 27650283
[TBL] [Abstract][Full Text] [Related]
5. Pre-existing mutations in reverse transcriptase of hepatitis B virus in treatment-naive Chinese patients with chronic hepatitis B.
Xu J; Wu B; Wang JH; Huang L; Wang DY; Zhao L; Zhao GP; Wang Y
PLoS One; 2015; 10(3):e0117429. PubMed ID: 25821965
[TBL] [Abstract][Full Text] [Related]
6. [Identification of hepatitis B virus genotypes in patients with chronic hepatitis B from different nationalities in ethnic minority areas in Yunnan Province, China].
Bian ZQ; Hua ZL; Yan WY; Liu MQ; Wu DY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):681-6. PubMed ID: 16681927
[TBL] [Abstract][Full Text] [Related]
7. Coexistence of hepatitis B surface antigen and anti-HBs in Chinese chronic hepatitis B virus patients relating to genotype C and mutations in the S and P gene reverse transcriptase region.
Liu W; Hu T; Wang X; Chen Y; Huang M; Yuan C; Guan M
Arch Virol; 2012 Apr; 157(4):627-34. PubMed ID: 22222283
[TBL] [Abstract][Full Text] [Related]
8. Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naïve Chinese patients.
Liu BM; Li T; Xu J; Li XG; Dong JP; Yan P; Yang JX; Yan L; Gao ZY; Li WP; Sun XW; Wang YH; Jiao XJ; Hou CS; Zhuang H
Antiviral Res; 2010 Mar; 85(3):512-9. PubMed ID: 20034521
[TBL] [Abstract][Full Text] [Related]
9. A large-scale analysis study on the clinical and viral characteristics of hepatitis B infection with concurrence of hepatitis B surface or E antigens and their corresponding antibodies.
Xiang Y; Chen P; Xia JR; Zhang LP
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252163
[TBL] [Abstract][Full Text] [Related]
10. Pre-core/basal-core promoter and reverse transcriptase mutations in chronic HBV infected-patients.
Xu L; Chen EQ; Lei J; Liu L; Zhou TY; Gao Z; Tang H
Hepatogastroenterology; 2012; 59(113):212-5. PubMed ID: 22251541
[TBL] [Abstract][Full Text] [Related]
11. The modulation of HBsAg level by sI126T is affected by additional amino acid substitutions in the S region of HBV.
He L; Su M; Ou G; Wang L; Deng J; Zhuang H; Xiang K; Li T
Infect Genet Evol; 2019 Nov; 75():104006. PubMed ID: 31442597
[TBL] [Abstract][Full Text] [Related]
12. Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals.
Huang H; Wang J; Li W; Chen R; Chen X; Zhang F; Xu D; Lu F
J Clin Virol; 2018; 99-100():71-78. PubMed ID: 29353073
[TBL] [Abstract][Full Text] [Related]
13. A complete genomic analysis of hepatitis B virus genotypes and mutations in HBeAg-negative chronic hepatitis B in China.
Zhu L; Tse CH; Wong VW; Chim AM; Leung KS; Chan HL
J Viral Hepat; 2008 Jun; 15(6):449-58. PubMed ID: 18266648
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between serum HBV DNA level and HBsAg titer in HBeAg-positive pregnant women and impact of genomic variability of hepatitis B virus pre S/S regions on their correlations].
Zhang X; Yan L; Lu Y; Wei KP; Liu ZX; Xiao YW; Ding F; Zhuang H; Li J
Zhonghua Gan Zang Bing Za Zhi; 2018 Aug; 26(8):579-584. PubMed ID: 30317788
[No Abstract] [Full Text] [Related]
15. Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.
Bayliss J; Yuen L; Rosenberg G; Wong D; Littlejohn M; Jackson K; Gaggar A; Kitrinos KM; Subramanian GM; Marcellin P; Buti M; Janssen HLA; Gane E; Sozzi V; Colledge D; Hammond R; Edwards R; Locarnini S; Thompson A; Revill PA
Gut; 2017 Nov; 66(11):2013-2023. PubMed ID: 27534671
[TBL] [Abstract][Full Text] [Related]
16. Overlapping gene mutations of hepatitis B virus in a chronic hepatitis B patient with hepatitis B surface antigen loss during lamivudine therapy.
Lee SY; Choi MS; Lee D; Lee JH; Koh KC; Paik SW; Yoo BC
J Korean Med Sci; 2005 Jun; 20(3):433-7. PubMed ID: 15953865
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of the B2+C2 subgenotype mixture in patients with chronic hepatitis B in Eastern China.
Zhong J; Gao YQ; Sun XH; Zhu XJ; Li M
Acta Pharmacol Sin; 2012 Oct; 33(10):1271-6. PubMed ID: 22941290
[TBL] [Abstract][Full Text] [Related]
18. Genotyping and molecular characterization of hepatitis B virus in liver disease patients in Kenya.
Ochwoto M; Chauhan R; Gopalakrishnan D; Chen CY; Ng'ang'a Z; Okoth F; Kioko H; Kimotho J; Kaiguri P; Kramvis A
Infect Genet Evol; 2013 Dec; 20():103-10. PubMed ID: 23978387
[TBL] [Abstract][Full Text] [Related]
19. Mutations in reverse transcriptase region of HBV affect Hepatitis B surface antigen titers and its correlation with HBV DNA.
Shen H; Chen C; Ye C; Zhang H; Hang S; Chen M; Zhu Z; Xue Y; Liu L
J Infect Dev Ctries; 2019 Nov; 13(11):1062-1067. PubMed ID: 32087080
[TBL] [Abstract][Full Text] [Related]
20. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum.
Weinberger KM; Bauer T; Böhm S; Jilg W
J Gen Virol; 2000 May; 81(Pt 5):1165-74. PubMed ID: 10769057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
